Imagin Medical Inc.
IME
CNSX
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 787.20K | 915.30K | 1.04M | 1.06M | 1.35M |
| Depreciation & Amortization | 121.40K | 92.90K | 64.60K | 36.60K | 23.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.82M | 2.22M | 2.58M | 2.70M | 2.84M |
| Operating Income | -1.82M | -2.22M | -2.58M | -2.70M | -2.84M |
| Income Before Tax | -2.57M | -571.40K | -832.50K | -1.89M | -4.80M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.57 | -0.57 | -0.83 | -1.89 | -4.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.57M | -571.40K | -832.50K | -1.89M | -4.80M |
| EBIT | -1.82M | -2.22M | -2.58M | -2.70M | -2.84M |
| EBITDA | -1.69M | -2.12M | -2.51M | -2.66M | -2.81M |
| EPS Basic | -0.25 | -0.04 | -0.07 | -0.18 | -0.55 |
| Normalized Basic EPS | 0.06 | 0.19 | 0.17 | 0.10 | -0.38 |
| EPS Diluted | -0.25 | -0.04 | -0.07 | -0.18 | -0.55 |
| Normalized Diluted EPS | 0.06 | 0.19 | 0.17 | 0.10 | -0.38 |
| Average Basic Shares Outstanding | 42.87M | 42.04M | 41.21M | 40.00M | 38.73M |
| Average Diluted Shares Outstanding | 42.87M | 42.04M | 41.21M | 40.00M | 38.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
